中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Skyclarys
    Skyclarys
    departments：神经内科
    drug：胶囊
    Active：omaveloxolone
    indication：SKYCLARYS适用于治疗16岁及以上青少年和成年人弗里德里希的共济失调
    Licensor：Reata Pharmaceuticals, Inc.
    Approved Country/Region：FDA
    Approval time：2023-02-28